HomeGLSI • NASDAQ
add
Greenwich Lifesciences Inc
Previous close
$12.38
Day range
$11.50 - $12.72
Year range
$8.00 - $21.44
Market cap
161.15M USD
Avg Volume
36.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.73M | 9.03% |
Net income | -2.67M | -11.58% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.73M | -9.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.82M | -36.32% |
Total assets | 5.83M | -36.34% |
Total liabilities | 842.38K | 183.36% |
Total equity | 4.98M | — |
Shares outstanding | 13.14M | — |
Price to book | 32.58 | — |
Return on assets | -104.53% | — |
Return on capital | -125.67% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.67M | -11.58% |
Cash from operations | -2.58M | -43.50% |
Cash from investing | — | — |
Cash from financing | 1.18M | — |
Net change in cash | -1.40M | 22.11% |
Free cash flow | -2.22M | -41.32% |
About
Founded
2006
Headquarters
Website
Employees
3
